Search Results - "Bosch, Xavier"

Refine Results
  1. 1

    Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis by Bruni, Laia, Dr, Diaz, Mireia, PhD, Barrionuevo-Rosas, Leslie, MD, Herrero, Rolando, MD, Bray, Freddie, PhD, Bosch, F Xavier, MD, de Sanjosé, Silvia, MD, Castellsagué, Xavier, MD

    Published in The Lancet global health (01-07-2016)
    “…Summary Background Since 2006, many countries have implemented publicly funded human papillomavirus (HPV) immunisation programmes. However, global estimates of…”
    Get full text
    Journal Article
  2. 2

    HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis by Ndiaye, Cathy, PhD, Mena, Marisa, Dr, Alemany, Laia, MD, Arbyn, Marc, DrTMH, Castellsagué, Xavier, PhD, Laporte, Louise, BSc, Bosch, F Xavier, MD, de Sanjosé, Silvia, PhD, Trottier, Helen, PhD

    Published in The lancet oncology (01-11-2014)
    “…Summary Background We aimed to provide updated information about the global estimates of attributable fraction and type distribution of human papillomavirus…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia by Bosch, F. Xavier, Burchell, Ann N, Schiffman, Mark, Giuliano, Anna R, de Sanjose, Silvia, Bruni, Laia, Tortolero-Luna, Guillermo, Kjaer, Susanne Kruger, Muñoz, Nubia

    Published in Vaccine (19-08-2008)
    “…Abstract Worldwide human papillomavirus (HPV) prevalence in women with normal cytology at any given point in time is approximately 10% indicating that HPV is…”
    Get full text
    Journal Article
  6. 6

    Adult haemophagocytic syndrome by Ramos-Casals, Manuel, MD, Brito-Zerón, Pilar, MD, López-Guillermo, Armando, MD, Khamashta, Munther A, Prof, Bosch, Xavier, Dr

    Published in The Lancet (British edition) (26-04-2014)
    “…Summary Haemophagocytic syndromes (haemophagocytic lymphohistiocytosis) have a wide range of causes, symptoms, and outcomes, but all lead to a…”
    Get full text
    Journal Article
  7. 7

    Diagnostic Approach to the Complexity of IgG4-Related Disease by Stone, John H., MD, MPH, Brito-Zerón, Pilar, MD, PhD, Bosch, Xavier, MD, PhD, Ramos-Casals, Manuel, MD, PhD

    Published in Mayo Clinic proceedings (01-07-2015)
    “…Abstract IgG4-related disease (IgG4-RD) is a systemic disease characterized by the infiltration of IgG4-bearing plasma cells and, more importantly, distinctive…”
    Get full text
    Journal Article
  8. 8

    Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings by Bruni, Laia, Diaz, Mireia, Castellsagué, Mireia, Ferrer, Elena, Bosch, F. Xavier, de Sanjosé, Silvia

    Published in The Journal of infectious diseases (15-12-2010)
    “…Background. Baseline information on human papillomavirus (HPV) prevalence and type distribution is highly desirable to evaluate the impact of prophylactic HPV…”
    Get full text
    Journal Article
  9. 9

    The clinical spectrum of IgG4-related disease by Brito-Zerón, Pilar, Ramos-Casals, Manuel, Bosch, Xavier, Stone, John H

    Published in Autoimmunity reviews (01-12-2014)
    “…Abstract IgG4-related disease (IgG4-RD) is an emerging immune-mediated disease with the capability of involving essentially any organ. The epidemiology of this…”
    Get full text
    Journal Article
  10. 10

    Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions by Serrano, Beatriz, de Sanjosé, Silvia, Tous, Sara, Quiros, Beatriz, Muñoz, Nubia, Bosch, Xavier, Alemany, Laia

    Published in European journal of cancer (1990) (01-09-2015)
    “…Abstract Objective Human papillomavirus (HPV) vaccines can potentially control cervical cancer and help to reduce other HPV-related cancers. We aimed to…”
    Get full text
    Journal Article
  11. 11
  12. 12

    HPV prevention and control – The way forward by Vorsters, Alex, Bosch, F. Xavier, Poljak, Mario, Waheed, Dur-e-Nayab, Stanley, Margaret, Garland, Suzanne M.

    Published in Preventive medicine (01-03-2022)
    “…The global confrontation with COVID-19 has not only diverted current healthcare resources to deal with the infection but has also resulted in increased…”
    Get full text
    Journal Article
  13. 13

    The cryoglobulinaemias by Ramos-Casals, Manuel, MD, Stone, John H, MD, Cid, Maria C, MD, Bosch, Xavier, Dr

    Published in The Lancet (British edition) (28-01-2012)
    “…Summary Cryoglobulins are immunoglobulins that precipitate in vitro at temperatures less than 37°C and produce organ damage through two main pathways: vascular…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Epidemiology and burden of HPV-related disease by Serrano, Beatriz, Brotons, María, Bosch, Francesc Xavier, Bruni, Laia

    “…Human papillomavirus (HPV) infection is recognized as one of the major causes of infection-related cancer in both men and women. High-risk HPV types are not…”
    Get full text
    Journal Article
  16. 16

    Progranulin: a growth factor, a novel TNFR ligand and a drug target by Liu, Chuan-ju, Bosch, Xavier

    Published in Pharmacology & therapeutics (Oxford) (01-01-2012)
    “…Progranulin (PGRN) is abundantly expressed in epithelial cells, immune cells, neurons, and chondrocytes, and reportedly contributes to tumorigenesis. PGRN is a…”
    Get full text
    Journal Article
  17. 17

    HPV vaccination: Are we overlooking additional opportunities to control HPV infection and transmission? by Vorsters, Alex, Van Damme, Pierre, Bosch, F. Xavier

    “…•Human papillomavirus virus-like particles have distinctive immunogenic properties generating high-quality neutralizing antibodies.•Systemic circulating…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20